Combination Therapy Use and Associated Events in Clinical Practice Following Dissemination of Trial Findings: A De-Implementation Study Using Interrupted Time Series Analysis-Reference-Cited by-同舟云学术

Combination Therapy Use and Associated Events in Clinical Practice Following Dissemination of Trial Findings: A De-Implementation Study Using Interrupted Time Series Analysis

Published:2024-01 Issue:1 Volume:46 Page:40-49
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Campbell Heather M.^ORCID,Murata Allison E.,Henrie Adam M.,Conner Todd A.

Funder

Health Services Research and Development

U.S. Department of Veterans Affairs

Office of Research and Development

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference69 articles.

1. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus;Hughes;Pharmacotherapy,2005

2. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL;de Zeeuw;Kidney Int,2004

3. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy;Atkins;Am J Kidney Dis,2005

4. Randomized controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril in microalbuminuria (CALM) study;Mogensen;BMJ,2000

5. Efficacy of ACE inhibitors and ATII receptor blockers in patients with microalbuminuria: a prospective study;Tutuncu;Acta Diabetol,2001

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing TSH testing: minimizing overdiagnosis and unnecessary interventions;Hypothyroidism - Causes, Screening and Therapeutic Approaches [Working Title];2024-04-26